Sung-ho Goh
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Synergistic Enhancement of Antitumor Effects by Combining Abemaciclib with Desipramine.
Journal: International journal of molecular sciences
Published: June 05, 2024
Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without EGFR or ALK Alterations.
Journal: Cancer research
Published: May 26, 2023
FOXM1 Inhibition Enhances the Therapeutic Outcome of Lung Cancer Immunotherapy by Modulating PD-L1 Expression and Cell Proliferation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 08, 2022
ELF3 Is a Target That Promotes Therapeutic Efficiency in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Cells via Inhibiting PKCί.
Journal: International journal of molecular sciences
Published: October 18, 2021
Comparison between MGI and Illumina sequencing platforms for whole genome sequencing.
Journal: Genes & genomics
Published: December 15, 2020
FAM188B Expression Is Critical for Cell Growth via FOXM1 Regulation in Lung Cancer.
Journal: Biomedicines
Published: October 07, 2020
Quenched cetuximab conjugate for fast fluorescence imaging of EGFR-positive lung cancers.
Journal: Biomaterials science
Published: August 08, 2020
Fibronectin regulates anoikis resistance via cell aggregate formation.
Journal: Cancer letters
Published: August 07, 2020
The clinical impact of family history of cancer in female never-smoker lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 26, 2019
Last Updated: 09/26/2026